Don't Miss The World's #1 Executive Networking Event"
- story •
- 3 min read
[Video] This Is How Billionaire Boris Jordan Thinks The Cannabis Industry Will Look Like In The Future
"I'm always thinking five years ahead, where's my growth going to come from? My personal view is that the United States… growth is going to start to slow a little bit," said Boris Jordan of Curaleaf Holdings Inc (OTC:CURLF) at the Benzinga Cannabis Capital Conference held last April.
Now, the event is coming to Chicago. Come and meet extraordinary cannabis visionaries like Boris Jordan and let’s network and learn together.
Join us on September 13 & 14 at the Benzinga Cannabis Capital Conference and stay at the historic Palmer House Hotel.
Don't miss out on a chance to hear about future market forecasts and worldly advice on investing and finance from those embedded in the cannabis industry. Ready, set, go!
Book your tickets HERE, and your room HERE.
Transcript (auto-generated)
in the short term we have our hurdles
and that we have to manufacture in every
state we have to grow in every state we
have to distribute in every state but
for the most part i think that where
we're going to go is interstate commerce
you know large hubs for distribution
around the country
and eventually moving out into the world
at large and the reason we decided to
cure leaf to go is that i'm always
thinking five years ahead where's my
growth going to come from
and you know i my personal view is that
the united states although at the
beginning of its journey
is going to start seeing and we're
seeing it in some states particularly
limited license states we're starting to
see some level of competition i think
growth is going to start to slow a
little bit
and so i was thinking where am i going
to get to growth five years from now my
investors want to know that this
business is going to continue to have
double digit growth and i know one thing
about europe i built a very big data
center business in europe over the years
and i know that it takes a long time the
ramp up in europe is much longer than as
united states it's hard here but in
europe it's even harder and so it's
mostly a pharmaceutical model in europe
at the moment it is moving to adult use
in germany in early 24 and i wanted to
make sure we were there with our brands
and and with our people and so that's
why we made the investment in europe and
we're starting to build out the
infrastructure there getting ready for
especially for adult use in germany in
2024
igniteit
August 26, 2022